Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs Oyaert

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Clinical Chemistry and Laboratory Medicine|April 20, 2023
Pitfalls in the diagnosis of hematuriaJoris Delanghe, Marijn Speeckaert, Sigurd Delanghe, et al.
Clinical Chemistry and Laboratory Medicine|December 21, 2019
Renal tubular epithelial cells add value in the diagnosis of upper urinary tract pathologyMatthijs Oyaert, Marijn Speeckaert, Jerina Boelens, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2019
Estimated urinary osmolality based on combined urinalysis parameters: a critical evaluationMatthijs Oyaert, Marijn M Speeckaert, Joris R Delanghe
Clinical Chemistry and Laboratory Medicine|September 7, 2022
Improving clinical performance of urine sediment analysis by implementation of intelligent verification criteriaMatthijs Oyaert, Sena Maghari, Marijn Speeckaert, et al.
Therapeutic Drug Monitoring|January 5, 2022
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry AnalyzersNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2021
Reformulated Architect<sup>®</sup> cyclosporine CMIA assay: improved imprecision, worse comparability between methodsNick Verougstraete, Alain G Verstraete, Veronique Stove, et al.
Cancers|April 26, 2025
Novel Urinary Biomarkers for the Detection of Bladder CancerMatthijs Oyaert, Charles Van Praet, Charlotte Delrue, et al.
Therapeutic Drug Monitoring|July 25, 2023
Comment on "Significant Improvement in Digoxin Immunoassays Over Four Decades: Newer Assays Are Less Affected by Interferences." The Case of Apalutamide InterferenceYorich Maenhout, Matthijs Oyaert, Iris Duroi, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2015
Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital settingMatthijs Oyaert, Xavier Bossuyt, Isabelle Ravelingien, et al.
Alzheimer'S Research & Therapy|March 1, 2026
Automated high-throughput quantification of plasma p-tau217 and APOE-ε4 for Alzheimer's disease diagnosis and cognitive decline in a memory cohortJochen Titeca, Marta Scarioni, Matthijs Oyaert, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Clinical Chemistry and Laboratory Medicine|April 20, 2023
Pitfalls in the diagnosis of hematuriaJoris Delanghe, Marijn Speeckaert, Sigurd Delanghe, et al.
Clinical Chemistry and Laboratory Medicine|December 21, 2019
Renal tubular epithelial cells add value in the diagnosis of upper urinary tract pathologyMatthijs Oyaert, Marijn Speeckaert, Jerina Boelens, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2019
Estimated urinary osmolality based on combined urinalysis parameters: a critical evaluationMatthijs Oyaert, Marijn M Speeckaert, Joris R Delanghe
Clinical Chemistry and Laboratory Medicine|September 7, 2022
Improving clinical performance of urine sediment analysis by implementation of intelligent verification criteriaMatthijs Oyaert, Sena Maghari, Marijn Speeckaert, et al.
Therapeutic Drug Monitoring|January 5, 2022
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry AnalyzersNick Verougstraete, Veronique Stove, Alain G Verstraete, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2021
Reformulated Architect<sup>®</sup> cyclosporine CMIA assay: improved imprecision, worse comparability between methodsNick Verougstraete, Alain G Verstraete, Veronique Stove, et al.
Cancers|April 26, 2025
Novel Urinary Biomarkers for the Detection of Bladder CancerMatthijs Oyaert, Charles Van Praet, Charlotte Delrue, et al.
Therapeutic Drug Monitoring|July 25, 2023
Comment on "Significant Improvement in Digoxin Immunoassays Over Four Decades: Newer Assays Are Less Affected by Interferences." The Case of Apalutamide InterferenceYorich Maenhout, Matthijs Oyaert, Iris Duroi, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2015
Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital settingMatthijs Oyaert, Xavier Bossuyt, Isabelle Ravelingien, et al.
Alzheimer'S Research & Therapy|March 1, 2026
Automated high-throughput quantification of plasma p-tau217 and APOE-ε4 for Alzheimer's disease diagnosis and cognitive decline in a memory cohortJochen Titeca, Marta Scarioni, Matthijs Oyaert, et al.
Pageof 8